Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus

The aim of this retrospective multicenter study was to clarify the antifibrotic effect and long‐term outcome of sodium glucose cotransporter 2 inhibitors (SGLT2‐Is) in patients with nonalcoholic fatty liver disease (NAFLD) complicated by type 2 diabetes mellitus (T2DM). Of the 1262 consecutive patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Mikami, Shigeru, Haruki, Uojima, Yoshikata, Keiichiro, Ono, Hiroki, Kawano, Tadamichi, Yoshida, Yuji, Tanabe, Tomohide, Okubo, Tomomi, Hayama, Korenobu, Nakagawa‐Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Nagao, Mototsugu, Inagaki, Kyoko, Fukuda, Izumi, Sugihara, Hitoshi, Iwakiri, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592771/
https://www.ncbi.nlm.nih.gov/pubmed/36039537
http://dx.doi.org/10.1002/hep4.2069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592771/
https://www.ncbi.nlm.nih.gov/pubmed/36039537
http://dx.doi.org/10.1002/hep4.2069

Ejemplares similares